Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus
about
Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa RicaEstimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccinationTouchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus.Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.DNA microarray format for detection and subtyping of human papillomavirus.Microarrays for genotyping human group a rotavirus by multiplex capture and type-specific primer extension.Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types.Prevalence of human papillomavirus in Indonesia: a population-based study in three regions.Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the NetherlandsHuman papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients.Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from ItalyAbundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assayHuman papillomavirus infection and squamous cell carcinoma of the conjunctiva.Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of ItalyHuman papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays.comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.High frequency of gastric colonization with multiple Helicobacter pylori strains in Venezuelan subjects.Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.Type distribution of human papillomavirus among adult women diagnosed with invasive cervical cancer (stage 1b or higher) in New Zealand.Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay.GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities.Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.Development of a bead-based multiplex genotyping method for diagnostic characterization of HPV infectionMolecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16.High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil.Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer.High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women.AKT1 loss correlates with episomal HPV16 in vulval intraepithelial neoplasia.The etiologic role of human papillomavirus in penile cancers: a study in Vietnam.Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural EthiopiaHuman papillomavirus-16 presence and physical status in lung carcinomas from AsiaResults of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.Bead-based multiplex genotyping of human papillomaviruses.Global proficiency study of human papillomavirus genotyping.
P2860
Q21089767-ADEA89A7-9620-41DF-9DC3-E1C4C2DAF533Q21261267-D795BC28-9588-48ED-A91E-5E554078B2DAQ24811477-17055C9E-16B7-4B77-AEF3-78E8D6DF2F66Q30354637-41ED7559-67BF-4215-AE4D-A2AF6E7DD26AQ30970916-14A66007-3767-444E-B275-8C00DEEB1C90Q31058927-F474DA13-07D1-407C-82B7-9DB60CDD85F3Q33194720-00A7BDEA-D76F-4621-A64B-739A109F64ABQ33349196-60547C73-D89B-4559-8C12-06D4A28610C3Q33349978-C35EE2FB-F743-4FC1-A5A5-F03C275CCA10Q33384636-064854E4-6469-41E9-A3FF-27A5C7CB667CQ33401974-ED0936D9-C2DA-456E-8287-9D4E6CF489B7Q33546704-65EFC438-11A4-4894-8428-52CD157AC7FCQ33595321-CE0B00D2-CD2A-4140-8E6A-2608947FB19EQ33614132-68D867CB-AA5B-4F18-B9AC-B911AFDA2ABBQ33630795-D59F049C-D29E-4BA1-963F-41339F7522D9Q33633372-6C432E5C-18B1-46D8-AE07-30B1C5859D61Q33769465-8D5629EC-BFEF-4515-9EB8-AFD4F92AD3B1Q33856287-8C3BFD24-081E-4973-BDDF-92613F6DB50AQ33856405-02C5BA42-324D-442D-BB94-903796DA3E5BQ33863369-59A303F4-AD55-4A53-84E8-BF0E10A995E3Q33904416-F586257E-A8EB-403E-876F-10CF78B8C17AQ33950256-6B9CD60D-65AC-4BBB-97D5-406849C3D289Q33950682-8F805F9B-02CF-4658-BF7D-0B74FD970A8FQ33950978-C5CEDA58-9E46-435B-AACB-FA2B7071CBACQ34074208-27D3F36A-0F1A-4A81-B2CD-EC635D4426A9Q34149348-FADE2C42-25A0-4C84-86D4-6E55084C3CA9Q34185819-5DF7020E-C445-492F-AF1F-C46D599E5CEBQ34196510-EE729BEE-1F42-442F-95FD-DA7AD481BBBFQ34197471-90D48EDB-0975-40A2-A723-C5A0AC286E6EQ34198635-AB4333A7-38DA-4C90-9F85-FE165A61CD63Q34231736-CF455148-4F52-4284-95C7-EF6C0769CAC8Q34267472-E9D267C8-BC3A-4B6D-BCC7-279F67F0C95BQ34291189-B09BE863-45A9-47F7-8F06-FFCE11901783Q34299690-24A5EA86-22B5-4811-9878-CFE07F3DD9A2Q34321558-C299AEB7-EAC8-4391-9BA7-ACC588450193Q34340212-334D76BB-6BBF-43F8-A190-447DDEBFE392Q34366447-FC21A943-3F93-4AC8-AC6A-D62E3B62483BQ34430779-A76F8EEC-1AD1-4FA3-8973-24FB9DA15D44Q34430808-8279D620-5FAF-437A-831F-987ECDF9C880Q34489632-770D0354-225E-4D9A-8C44-778EF48FB8AB
P2860
Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Development and clinical evalu ...... nogenital human papillomavirus
@ast
Development and clinical evalu ...... nogenital human papillomavirus
@en
type
label
Development and clinical evalu ...... nogenital human papillomavirus
@ast
Development and clinical evalu ...... nogenital human papillomavirus
@en
prefLabel
Development and clinical evalu ...... nogenital human papillomavirus
@ast
Development and clinical evalu ...... nogenital human papillomavirus
@en
P2093
P2860
P1476
Development and clinical evalu ...... nogenital human papillomavirus
@en
P2093
Lindeman J
Sastrowijoto S
Schrauwen L
ter Harmsel B
ter Schegget J
van Doorn LJ
P2860
P304
P407
P577
1999-08-01T00:00:00Z